About:
Owkin is using artificial intelligence to identify new treatments and diagnostics. Cancer is a highly heterogeneous disease, with one cancer tissue containing many subtypes that may respond differently to treatments. By exploiting this additional layer of information that can be gathered from pathology slides, Owkin is offering solutions to give healthcare providers a fuller picture of a patient’s disease such that more patients can benefit from targeted therapies. However, Owkin is also using AI to identify new drug candidates, de-risk and accelerate clinical trials as well as building diagnostic solutions.
Associate Director, Strategic Pharma Accounts Boston, NY|14 days ago
Corporate Development Intern Paris, Île-de-France, France|15 days ago
Head of Clinical Translational Medicine London, England, United Kingdom|20 days ago
Data Engineer Nantes, Pays de la Loire, France|21 days ago
Sales Director, Life Science Accounts Boston, NY|21 days ago
Senior Frontend Engineer France|28 days ago
Senior Frontend Engineer Paris, Île-de-France, France|28 days ago
Senior Frontend Engineer Nantes, Pays de la Loire, France|28 days ago
Data Engineer Nantes, Pays de la Loire, France|35 days ago
**** ******** *****, Î**-**-******, ******|43 days ago
Data Engineer France|43 days ago
Marketing Intern (Generalist) Paris, Île-de-France, France|50 days ago
********** ****** - ****** ******* *****, Î**-**-******, ******|55 days ago
Data Engineer Paris, Île-de-France, France|79 days ago
Data Engineer France|79 days ago
Data Portfolio Intern Paris, Île-de-France, France|Not provided
Head of Clinical Translational Medicine Berlin, Germany|Not provided